ASMTLAS: A Protein Regulating Mitochondrial Function and Energy Metabolism

Target Name: ASMTL-AS1

NCBI ID: G80161

ASMTL-AS1

ASMTLAS: A Protein Regulating Mitochondrial Function and Energy Metabolism

ASMTL-AS1, also known as ASMTLAS or ALDH1801, is a protein that is expressed in the liver and other tissues in the body. It is a member of the ASMTL family, which is known for its role in the regulation of mitochondrial function and energy metabolism.

ASMTLAS is a 21-kDa protein that is expressed in the liver, spleen, and kidneys. It is highly conserved across species, with only minor differences in its amino acid sequence between different species. ASMTLAS is a cytoplasmic protein, which means that it is located in the cytoplasm of cells, rather than in the cell nucleus.

ASMTLAS plays a crucial role in the regulation of mitochondrial function and energy metabolism. It is a key protein for the detoxification of xenobiotics, such as drugs and other harmful substances that are ingested or injected into the body. This is done by the mitochondria, which are organelles that are responsible for generating ATP, the energy currency of the cell.

ASMTLAS is also involved in the regulation of cellular signaling pathways that are important for cell growth, apoptosis (programmed cell death), and inflammation. It is a key regulator of the unfolded protein response (UPR), which is a critical pathway that helps cells respond to and recover from various stressors, such as UV radiation, drugs, and other harmful substances.

ASMTLAS is also involved in the regulation of inflammation, which is a critical part of the immune response. It is a key regulator of the production of pro-inflammatory cytokines, which are important for the recruitment of immune cells to the site of an infection or inflammation.

ASMTLAS is a potential drug target because of its involvement in the regulation of mitochondrial function and energy metabolism. Many drugs that are used to treat a wide range of diseases, such as cancer, diabetes, and neurodegenerative diseases, work by modulating the activity of mitochondria. Therefore, ASMTLAS is a promising target for the development of new drugs that can treat a wide range of diseases.

In addition to its potential as a drug target, ASMTLAS is also a potential biomarker for the diagnosis and monitoring of various diseases. For example, altered levels of ASMTLAS have been observed in the brains of individuals with Alzheimer's disease, which is a degenerative brain disorder that is characterized by the progressive loss of brain cells. Therefore, ASMTLAS may be a useful biomarker for the diagnosis and monitoring of Alzheimer's disease.

ASMTLAS is also a potential target for the development of new therapies for the treatment of other diseases. For example, it is involved in the regulation of the production of pro-inflammatory cytokines, which can contribute to the development of inflammatory diseases such as rheumatoid arthritis and Crohn's disease. Therefore, ASMTLAS may be a useful target for the development of new therapies for these diseases.

In conclusion, ASMTLAS is a protein that is expressed in the liver and other tissues in the body. It is a member of the ASMTL family and plays a crucial role in the regulation of mitochondrial function and energy metabolism. ASMTLAS is also involved in the regulation of cellular signaling pathways that are important for cell growth, apoptosis, and inflammation. ASMTLAS is a potential drug target and biomarker for the diagnosis and treatment of a wide range of diseases. Further research is needed to fully understand the role of ASMTLAS in the regulation of cellular function and the development of new drugs and therapies.

Protein Name: ASMTL Antisense RNA 1

The "ASMTL-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ASMTL-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets